COVID-19 Impact on Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Drug Substance Development and Manufacturing
  • 1.4.3 Specialized Services
  • 1.4.4 Lab-based Services
• 1.5 Market by Application
  • 1.5.1 Global Pharmaceutical CDMO Services Market Share by Application: 2020 VS 2026
  • 1.5.2 Innovative Medicine
  • 1.5.3 Patented Drug
  • 1.5.4 Patent Expired Drug
• 1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutical CDMO Services Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Pharmaceutical CDMO Services Industry
    • 1.6.1.1 Pharmaceutical CDMO Services Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Pharmaceutical CDMO Services Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Pharmaceutical CDMO Services Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Pharmaceutical CDMO Services Market Perspective (2015-2026)
• 2.2 Pharmaceutical CDMO Services Growth Trends by Regions
  • 2.2.1 Pharmaceutical CDMO Services Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Pharmaceutical CDMO Services Historic Market Share by Regions (2015-2020)
  • 2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Pharmaceutical CDMO Services Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Pharmaceutical CDMO Services Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Pharmaceutical CDMO Services Players by Market Size
  • 3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2015-2020)
  • 3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Pharmaceutical CDMO Services Market Concentration Ratio
  • 3.2.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2019
• 3.3 Pharmaceutical CDMO Services Key Players Head office and Area Served
• 3.4 Key Players Pharmaceutical CDMO Services Product Solution and Service
• 3.5 Date of Enter into Pharmaceutical CDMO Services Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2015-2020)
• 4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical CDMO Services Breakdown Data by Application (2015-2026)

• 5.1 Global Pharmaceutical CDMO Services Market Size by Application (2015-2020)
• 5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Pharmaceutical CDMO Services Market Size (2015-2020)
• 6.2 Pharmaceutical CDMO Services Key Players in North America (2019-2020)
• 6.3 North America Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 6.4 North America Pharmaceutical CDMO Services Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Pharmaceutical CDMO Services Market Size (2015-2020)
• 7.2 Pharmaceutical CDMO Services Key Players in Europe (2019-2020)
• 7.3 Europe Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 7.4 Europe Pharmaceutical CDMO Services Market Size by Application (2015-2020)

8 China

• 8.1 China Pharmaceutical CDMO Services Market Size (2015-2020)
• 8.2 Pharmaceutical CDMO Services Key Players in China (2019-2020)
• 8.3 China Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 8.4 China Pharmaceutical CDMO Services Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Pharmaceutical CDMO Services Market Size (2015-2020)
• 9.2 Pharmaceutical CDMO Services Key Players in Japan (2019-2020)
• 9.3 Japan Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 9.4 Japan Pharmaceutical CDMO Services Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Pharmaceutical CDMO Services Market Size (2015-2020)
• 10.2 Pharmaceutical CDMO Services Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 10.4 Southeast Asia Pharmaceutical CDMO Services Market Size by Application (2015-2020)

11 India

• 11.1 India Pharmaceutical CDMO Services Market Size (2015-2020)
• 11.2 Pharmaceutical CDMO Services Key Players in India (2019-2020)
• 11.3 India Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 11.4 India Pharmaceutical CDMO Services Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Pharmaceutical CDMO Services Market Size (2015-2020)
• 12.2 Pharmaceutical CDMO Services Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Pharmaceutical CDMO Services Market Size by Type (2015-2020)
• 12.4 Central & South America Pharmaceutical CDMO Services Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Recipharm AB
  • 13.1.1 Recipharm AB Company Details
  • 13.1.2 Recipharm AB Business Overview and Its Total Revenue
  • 13.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction
  • 13.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2015-2020))
  • 13.1.5 Recipharm AB Recent Development
• 13.2 AMRI Global
  • 13.2.1 AMRI Global Company Details
  • 13.2.2 AMRI Global Business Overview and Its Total Revenue
  • 13.2.3 AMRI Global Pharmaceutical CDMO Services Introduction
  • 13.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.2.5 AMRI Global Recent Development
• 13.3 Patheon N.V.
  • 13.3.1 Patheon N.V. Company Details
  • 13.3.2 Patheon N.V. Business Overview and Its Total Revenue
  • 13.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction
  • 13.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.3.5 Patheon N.V. Recent Development
• 13.4 Aenova Group
  • 13.4.1 Aenova Group Company Details
  • 13.4.2 Aenova Group Business Overview and Its Total Revenue
  • 13.4.3 Aenova Group Pharmaceutical CDMO Services Introduction
  • 13.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.4.5 Aenova Group Recent Development
• 13.5 Catalent, Inc.
  • 13.5.1 Catalent, Inc. Company Details
  • 13.5.2 Catalent, Inc. Business Overview and Its Total Revenue
  • 13.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction
  • 13.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.5.5 Catalent, Inc. Recent Development
• 13.6 Amatsigroup
  • 13.6.1 Amatsigroup Company Details
  • 13.6.2 Amatsigroup Business Overview and Its Total Revenue
  • 13.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction
  • 13.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.6.5 Amatsigroup Recent Development
• 13.7 WuXi AppTec Group
  • 13.7.1 WuXi AppTec Group Company Details
  • 13.7.2 WuXi AppTec Group Business Overview and Its Total Revenue
  • 13.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction
  • 13.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.7.5 WuXi AppTec Group Recent Development
• 13.8 Strides Pharma Science Limited
  • 13.8.1 Strides Pharma Science Limited Company Details
  • 13.8.2 Strides Pharma Science Limited Business Overview and Its Total Revenue
  • 13.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction
  • 13.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.8.5 Strides Pharma Science Limited Recent Development
• 13.9 Piramal Pharma Solutions
  • 13.9.1 Piramal Pharma Solutions Company Details
  • 13.9.2 Piramal Pharma Solutions Business Overview and Its Total Revenue
  • 13.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction
  • 13.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.9.5 Piramal Pharma Solutions Recent Development
• 13.10 Siegfried Ltd
  • 13.10.1 Siegfried Ltd Company Details
  • 13.10.2 Siegfried Ltd Business Overview and Its Total Revenue
  • 13.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction
  • 13.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 13.10.5 Siegfried Ltd Recent Development
• 13.11 Fareva Group
  • 10.11.1 Fareva Group Company Details
  • 10.11.2 Fareva Group Business Overview and Its Total Revenue
  • 10.11.3 Fareva Group Pharmaceutical CDMO Services Introduction
  • 10.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 10.11.5 Fareva Group Recent Development
• 13.12 FAMAR Health Care Services
  • 10.12.1 FAMAR Health Care Services Company Details
  • 10.12.2 FAMAR Health Care Services Business Overview and Its Total Revenue
  • 10.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction
  • 10.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2015-2020)
  • 10.12.5 FAMAR Health Care Services Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer